1. Home
  2. TRVG vs LCTX Comparison

TRVG vs LCTX Comparison

Compare TRVG & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo trivago N.V.

TRVG

trivago N.V.

BUY

Current Price

$3.98

Market Cap

282.2M

Sector

Technology

ML Signal

BUY

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

SELL

Current Price

$0.98

Market Cap

251.4M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
TRVG
LCTX
Founded
2005
1990
Country
Germany
United States
Employees
893
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
282.2M
251.4M
IPO Year
2015
1996

Fundamental Metrics

Financial Performance
Metric
TRVG
LCTX
Price
$3.98
$0.98
Analyst Decision
Hold
Strong Buy
Analyst Count
5
7
Target Price
★ $5.95
$5.50
AVG Volume (30 Days)
178.3K
★ 1.5M
Earning Date
11-03-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $14,556,000.00
Revenue This Year
$15.24
$4.38
Revenue Next Year
$9.60
$10.80
P/E Ratio
$16.98
★ N/A
Revenue Growth
N/A
★ 53.24
52 Week Low
$2.59
$0.88
52 Week High
$6.80
$2.09

Technical Indicators

Market Signals
Indicator
TRVG
LCTX
Relative Strength Index (RSI) 28.79 50.66
Support Level $2.72 $0.88
Resistance Level $5.77 $1.05
Average True Range (ATR) 0.27 0.06
MACD -0.10 0.01
Stochastic Oscillator 3.33 68.16

Price Performance

Historical Comparison
TRVG
LCTX

About TRVG trivago N.V.

trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments, namely the Americas, Developed Europe, and the Rest of the World. Its geographic areas are the United States, Germany, the United Kingdom, Canada, Japan, and all other countries.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

Share on Social Networks: